Aktie A3ERTB HONGCHANG INTERNATIONAL CO., LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Hongchang International Co., Ltd

Aktien

A3ERTB

US42831T2024

HCIL

Markt geschlossen - OTC Markets
Andere Börsenplätze
 15:31:03 06.05.2024 		% 5 Tage % 1. Jan.
0,2501 USD +12,35 % Intraday Chart für Hongchang International Co., Ltd +12,35 % -28,30 %
01.04. Hongchang International Co., Ltd berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI
01.04. Hongchang International Co. Ltd. gibt Veränderungen im Vorstand bekannt CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Hongchang International Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Hongchang International Co., Ltd Announces Board Changes
Hongchang International Co., Ltd. has Changed its Ticker to HCIL from HYBT
Heyu Biological Technology Corporation has Changed its Name to Hongchang International Co., Ltd
Hongchang International Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Hong Chang Biotechnologies (HK) Limited completed the acquisition of Heyu Biological Technology Corporation (OTCPK:HYBT.D) in a reverse merger transaction.
Heyu Biological Technology Corporation Appoints Zengqiang Lin as the Chief Executive Officer
Heyu Biological Technology Corporation Announces Board and Executive Changes
Heyu Biological Technology Corporation Appoints Wendy Wei Li as the Chief Financial Officer of the Company
Hong Chang Biotechnologies (HK) Limited entered into an agreement to acquire Heyu Biological Technology Corporation (OTCPK:HYBT.D) in a reverse merger transaction for HKD 4.4 billion.
Heyu Biological Technology Corporation Reports Earnings Results for the Half Year Ended June 30, 2023
Insider Buy: Heyu Biological Technology
Heyu Biological Technology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
HEYU BIOLOGICAL TECHNOLOGY CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Heyu Biological Technology Corporation Auditor Raises 'Going Concern' Doubt
HEYU BIOLOGICAL TECHNOLOGY : ANNOUNCES APPOINTMENT OF NEW INDEPENDENT DIRECTOR - Form 8-K
HEYU BIOLOGICAL TECHNOLOGY CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Heyu Biological Technology Corporation Appoints Zengqiang Lin as an Independent Director of the Company
HEYU BIOLOGICAL TECHNOLOGY CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Heyu Biological Technology Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3ERTB Aktie
  4. Nachrichten Hongchang International Co., Ltd
  5. Andere Sprachen